0 XP   0   0   0

PTC Therapeutics Inc
Buy or Sell?

I guess you are interested in PTC Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of PTC Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is PTC Therapeutics Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how PTC Therapeutics Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value PTC Therapeutics Inc. The closing price on 2022-09-23 was $49.16 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Daily chart of PTC Therapeutics Inc
PTC Therapeutics Inc Daily Candlestick Chart

1.1. Profitability of PTC Therapeutics Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin
  • Measures how much profit a company generates for each dollar of revenue.
  • Above 10% is considered healthy depending on the industry.
  • A net profit margin of 25% means that $0,25 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PTC Therapeutics Inc:

  • The MRQ is -91.9%. The company is losing money. -2
  • The TTM is -90.0%. The company is losing money. -2
Trends
Current periodCompared to+/- 
MRQ-91.9%TTM-90.0%-1.9%
TTM-90.0%YOY-83.0%-7.0%
TTM-90.0%5Y-86.2%-3.8%
5Y-86.2%10Y-286.5%+200.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-91.9%-242.4%+150.5%
TTM-90.0%-275.9%+185.9%
YOY-83.0%-335.9%+252.9%
5Y-86.2%-469.8%+383.6%
10Y-286.5%-549.9%+263.4%
1.1.2. Return on Assets
  • Shows how profitable a company is in relation to its total assets.
  • Above 5% is considered healthy depending on the industry.
  • 5% return on assets means the company generated $0,05 for each $1 in assets.

Let's take a look of the Return on Assets trends of PTC Therapeutics Inc:

  • The MRQ is -8.4%. Very bad. -2
  • The TTM is -7.4%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-8.4%TTM-7.4%-1.0%
TTM-7.4%YOY-4.6%-2.8%
TTM-7.4%5Y-5.5%-1.9%
5Y-5.5%10Y-9.3%+3.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.4%-9.8%+1.4%
TTM-7.4%-8.8%+1.4%
YOY-4.6%-9.2%+4.6%
5Y-5.5%-11.6%+6.1%
10Y-9.3%-12.7%+3.4%
1.1.3. Return On Equity
  • Measures the profit in relation to shareholders equity (total assets - total liabilities).
  • Above 15%-20% is considered healthy depending on the industry
  • 10% return on equity means the company generated $0,1 for each $1 the owners (shareholders) invested.

Let's take a look of the Return On Equity trends of PTC Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-2,522.5%+2,522.5%
TTM-2,522.5%YOY-33.3%-2,489.2%
TTM-2,522.5%5Y-519.3%-2,003.2%
5Y-519.3%10Y-268.4%-250.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--11.9%+11.9%
TTM-2,522.5%-11.2%-2,511.3%
YOY-33.3%-10.6%-22.7%
5Y-519.3%-13.7%-505.6%
10Y-268.4%-14.5%-253.9%

1.2. Operating Efficiency of PTC Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin
  • Measures how much profit a company makes for each $1 of sales after paying variable costs (production costs, wages) but before taxes.
  • Above 15% is considered healthy depending on the industry
  • An operating margin of 20% means the company generated $0,2 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PTC Therapeutics Inc:

  • The MRQ is -76.6%. Very bad. -2
  • The TTM is -73.4%. Very bad. -2
Trends
Current periodCompared to+/- 
MRQ-76.6%TTM-73.4%-3.2%
TTM-73.4%YOY-57.0%-16.4%
TTM-73.4%5Y-76.2%+2.8%
5Y-76.2%10Y-281.2%+205.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-76.6%-232.1%+155.5%
TTM-73.4%-269.6%+196.2%
YOY-57.0%-306.8%+249.8%
5Y-76.2%-461.8%+385.6%
10Y-281.2%-546.8%+265.6%
1.2.2. Operating Ratio
  • Measures how efficient the company is creating its products or services while keeping operating costs low.
  • Below 1 is considered healthy depending on the industry
  • An operation ratio of 0.5 means that the operating costs are $0,5 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of PTC Therapeutics Inc:

  • The MRQ is 1.650. Very good. +2
  • The TTM is 1.622. Very good. +2
Trends
Current periodCompared to+/- 
MRQ1.650TTM1.622+0.028
TTM1.622YOY1.705-0.083
TTM1.6225Y1.689-0.067
5Y1.68910Y6.585-4.896
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6503.321-1.671
TTM1.6223.662-2.040
YOY1.7053.692-1.987
5Y1.6895.743-4.054
10Y6.5856.919-0.334

1.3. Liquidity of PTC Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio
  • Measures if the company is able to pay off short-term debts (debts due within 1 year).
  • Above 1 is considered healthy depending on the industry.
  • A current ratio of 1.5 means the company has $1.5 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of PTC Therapeutics Inc:

  • The MRQ is 1.224. Neutral. Compare to industry.
  • The TTM is 1.724. Good. +1
Trends
Current periodCompared to+/- 
MRQ1.224TTM1.724-0.499
TTM1.724YOY4.370-2.646
TTM1.7245Y3.138-1.415
5Y3.13810Y6.070-2.932
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2245.318-4.094
TTM1.7246.219-4.495
YOY4.3706.366-1.996
5Y3.1386.760-3.622
10Y6.0706.520-0.450
1.3.2. Quick Ratio
  • Measures if the company is able to pay short-term debts (debts due within 1 year). But only uses the most liquid assets (cash, marketable securities and accounts retrievable).
  • Above 1 is considered healthy depending on the industry.
  • A quick ratio of 0,8 means the company can pay off $0,8 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PTC Therapeutics Inc:

  • The MRQ is 1.743. Very good. +2
  • The TTM is 2.654. Very good. +2
Trends
Current periodCompared to+/- 
MRQ1.743TTM2.654-0.911
TTM2.654YOY7.201-4.547
TTM2.6545Y4.435-1.782
5Y4.43510Y9.736-5.300
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7434.107-2.364
TTM2.6544.994-2.340
YOY7.2015.257+1.944
5Y4.4355.338-0.903
10Y9.7365.050+4.686

1.4. Solvency of PTC Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt To Asset Ratio
  • Shows if the company is owned by creditors or shareholders.
  • Below 1 (100%) is considered healthy depending on the industry
  • A debt to asset ratio of 0.45 (45%) means that the company is financed with 45% credit and 55% is financed by it's owners (shareholders).

Let's take a look of the Debt To Asset Ratio trends of PTC Therapeutics Inc:

  • The MRQ is 1.101. Bad. More debt than assets -1
  • The TTM is 1.025. Bad. More debt than assets -1
Trends
Current periodCompared to+/- 
MRQ1.101TTM1.025+0.076
TTM1.025YOY0.828+0.196
TTM1.0255Y0.737+0.288
5Y0.73710Y0.596+0.141
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1010.269+0.832
TTM1.0250.267+0.758
YOY0.8280.296+0.532
5Y0.7370.362+0.375
10Y0.5960.398+0.198
1.4.2. Debt to Equity Ratio
  • Measures the total debt versus the total shareholders equity (total assets - total liabilities).
  • Below 2 is considered healthy depending on the industry.
  • A debt to equity ratio of 0.84 means that company has $0,84 debt for each $1 in equity.

Let's take a look of the Debt to Equity Ratio trends of PTC Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM341.219-341.219
TTM341.219YOY5.635+335.583
TTM341.2195Y70.329+270.889
5Y70.32910Y35.470+34.859
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.305-0.305
TTM341.2190.303+340.916
YOY5.6350.309+5.326
5Y70.3290.382+69.947
10Y35.4700.436+35.034

2. Market Valuation of PTC Therapeutics Inc

2. Earnings
2.1. Price to Earnings Ratio
  • Compares the company's stock price to its earnings.
  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 15 means the investor is paying $15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PTC Therapeutics Inc:

  • The EOD is -6.278. Company is losing money. -2
  • The MRQ is -5.116. Company is losing money. -2
  • The TTM is -5.312. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-6.278MRQ-5.116-1.162
MRQ-5.116TTM-5.312+0.196
TTM-5.312YOY-7.568+2.256
TTM-5.3125Y-10.156+4.844
5Y-10.15610Y-9.402-0.754
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.278-2.088-4.190
MRQ-5.116-2.275-2.841
TTM-5.312-3.796-1.516
YOY-7.568-4.994-2.574
5Y-10.156-3.642-6.514
10Y-9.402-3.303-6.099
2.2. Price/Earnings-to-Growth Ratio

Let's take a look of the Price/Earnings-to-Growth Ratio trends of PTC Therapeutics Inc:

  • The MRQ is -0.132. Very Bad. -2
  • The TTM is -0.089. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-0.132TTM-0.089-0.043
TTM-0.089YOY-0.023-0.066
TTM-0.0895Y0.008-0.096
5Y0.00810Y-0.020+0.028
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.1320.005-0.137
TTM-0.0890.020-0.109
YOY-0.0230.041-0.064
5Y0.0080.021-0.013
10Y-0.0200.017-0.037

2. Books
2.3. Price to Book Ratio
  • Shows if the stock is under or overvalued compared to it's book value (total assets - total liabilities).
  • At or below 1 is considered healthy
  • A PB ratio of 3 means the investor is paying $3 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of PTC Therapeutics Inc:

  • The EOD is -19.255. Bad. Book ratio is negative. -2
  • The MRQ is -15.691. Bad. Book ratio is negative. -2
  • The TTM is 484.358. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD-19.255MRQ-15.691-3.564
MRQ-15.691TTM484.358-500.049
TTM484.358YOY10.314+474.045
TTM484.3585Y102.033+382.326
5Y102.03310Y52.657+49.376
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-19.2551.808-21.063
MRQ-15.6911.944-17.635
TTM484.3582.750+481.608
YOY10.3143.492+6.822
5Y102.0332.731+99.302
10Y52.6572.401+50.256

2.4. Latest News of PTC Therapeutics Inc

Does PTC Therapeutics Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from PTC Therapeutics Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-09-20
17:54
Investing in PTC Therapeutics (NASDAQ:PTCT) five years ago would have delivered you a 173% gainRead

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of PTC Therapeutics Inc.

3.1. Institutions holding PTC Therapeutics Inc

Institutions are holding 106.068% of the shares of PTC Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31FMR Inc15.00180.032107271451224601.1548
2022-03-31Wellington Management Company LLP11.39840.05218150541-4506-0.0553
2022-03-31Vanguard Group Inc9.69580.00616933076441670.6411
2022-03-31RTW INVESTMENTS, LLC7.30184.03185221228-72738-1.374
2022-03-31Franklin Resources Inc6.86950.07324912064308500.632
2022-03-31State Street Corporation4.45280.0059318402738259613.6572
2022-03-31Armistice Capital, LLC4.24582.190430360002118893231.041
2022-03-31HHG PLC3.75070.04832681974-1219423-31.2561
2022-06-30Camber Capital Management LLC3.42634.2582245000070000040
2022-03-31T. Rowe Price Associates, Inc.2.40320.00651718458-388103-18.4235
2022-03-31Loomis, Sayles & Company LP2.3030.082116467841105617.1969
2022-03-31Macquarie Group Ltd2.17170.04411552928301011.9767
2022-03-31Geode Capital Management, LLC1.80560.0061291139190091.4943
2022-03-31Bank of New York Mellon Corp1.49130.00771066395-50081-4.4856
2022-03-31D. E. Shaw & Co LP1.45080.03621037390-157590-13.1877
2022-03-31JPMorgan Chase & Co1.10440.003678973515833025.0758
2022-06-30TimesSquare Capital Management, LLC0.95920.3831685900-162505-19.1542
2022-03-31Northern Trust Corp0.94020.0044672323-36300-5.1226
2022-03-31Jacobs Levy Equity Management, Inc.0.88530.1589633030538149.2908
2022-03-31Charles Schwab Investment Management Inc0.71660.0057512380132012.6445
Total 82.374211.436358902517  

3.2. Funds holding PTC Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Fidelity® Select Biotechnology3.17171.8708226794400
2022-07-31SPDR® S&P Biotech ETF3.12421.29112233972-15626-0.6946
2022-07-31Vanguard Total Stock Mkt Idx Inv2.95270.0075211137110760.051
2022-07-31Vanguard Small Cap Index2.52330.0647180429449500.2751
2022-06-30Hartford MidCap Y2.21620.79431584741-581349-26.8386
2022-07-29iShares Russell 2000 ETF2.11620.123151319213200.0873
2022-07-31Franklin Biotechnology Discv A(acc)USD1.92243.47561374611-171687-11.1031
2022-06-30Vanguard Health Care Inv1.72820.109123574400
2022-06-30Fidelity® Select Health Care1.60770.5805114960000
2022-07-31Vanguard Small Cap Growth Index Inv1.48550.15761062218-4251-0.3986
2022-06-30Delaware Small Cap Core I1.46710.629104906900
2022-06-30Macquarie US Small Cap Core Equity1.46710.62971049069509335.1028
2022-06-30Fidelity Growth Compy Commingled Pl 31.46550.0873104794224550.2348
2022-06-30Franklin US Small Cap Growth Equity1.36131.547397340000
2022-06-30Franklin Small Cap Growth Adv1.36131.547397340000
2022-06-30Franklin Growth A1.34610.245796256400
2022-07-31Vanguard Extended Market Index Investor1.32630.047494834843480.4606
2022-06-30Fidelity® Growth Company1.2480.087892383-5329-0.5936
2022-06-30Fidelity Advisor® Health Care I1.11840.587379970000
2022-06-30Franklin Biotechnology Discovery A1.11793.953879940000
Total 36.127117.835925832962  

3.3. Insider Transactions

Insiders are holding 2.483% of the shares of PTC Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-08-09Stephanie OkeySELL229651.621867
2022-06-07Stuart Walter PeltzSELL40726.8338239
2022-04-19Eric PauwelsSELL82242.5249772
2022-04-19Matthew B KleinSELL89742.5256564
2022-04-14Stuart Walter PeltzSELL8245.2838646
2022-04-13Mark Elliott BouldingSELL227645.1761110
2022-04-05Mark Elliott BouldingSELL54561110
2022-03-31Emily Luisa HillSELL791037.78
2022-02-10Mark Elliott BouldingSELL1793545.03
2022-02-01Emily Luisa HillSELL55340
2022-02-01Stuart Walter PeltzSELL196140
2022-02-01Mark Elliott BouldingSELL77940
2022-02-01Eric PauwelsSELL36740
2022-02-01Christine Marie UtterSELL31340
2022-01-25Emily Luisa HillSELL21139.31
2022-01-25Eric PauwelsSELL35939.31
2022-01-25Stuart Walter PeltzSELL33039.31
2022-01-18Christine Marie UtterSELL1142843.94
2022-01-07Christine Marie UtterSELL74738.52
2022-01-07Emily Luisa HillSELL80038.52

4. Summary

4.1. Key Performance Indicators

The key performance indicators of PTC Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share---2.553-0.580-77%5.410-147%5.421-147%5.389-147%
Current Ratio--1.2241.724-29%4.370-72%3.138-61%6.070-80%
Debt To Asset Ratio--1.1011.025+7%0.828+33%0.737+49%0.596+85%
Debt To Equity Ratio---341.219-100%5.635-100%70.329-100%35.470-100%
Eps---2.131-1.958-8%-1.411-34%-1.301-39%-1.032-52%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---0.919-0.900-2%-0.830-10%-0.862-6%-2.865+212%
Operating Margin---0.766-0.734-4%-0.570-26%-0.7620%-2.812+267%
Operating Ratio--1.6501.622+2%1.705-3%1.689-2%6.585-75%
Pb Ratio-19.255-23%-15.691484.358-103%10.314-252%102.033-115%52.657-130%
Pe Ratio-6.278-23%-5.116-5.312+4%-7.568+48%-10.156+99%-9.402+84%
Peg Ratio---0.132-0.089-33%-0.023-83%0.008-1848%-0.020-85%
Price Per Share49.160+19%40.06038.603+4%49.350-19%39.523+1%30.664+31%
Quick Ratio--1.7432.654-34%7.201-76%4.435-61%9.736-82%
Return On Assets---0.084-0.074-12%-0.046-45%-0.055-35%-0.093+10%
Return On Equity----25.2250%-0.3330%-5.1930%-2.6840%
 EOD+2 -1MRQTTM+3 -11YOY+5 -95Y+4 -1010Y+7 -7

4.2. Fundamental Score

Let's check the fundamental score of PTC Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.278
Price to Book Ratio (EOD)Between0-1-19.255
Net Profit Margin (MRQ)Greater than0-0.919
Operating Margin (MRQ)Greater than0-0.766
Quick Ratio (MRQ)Greater than11.743
Current Ratio (MRQ)Greater than11.224
Debt To Asset Ratio (MRQ)Less than11.101
Debt to Equity Ratio (MRQ)Less than10.000
Return On Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.084
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of PTC Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.172
Ma 20Greater thanMa 5051.799
Ma 50Greater thanMa 10049.874
Ma 100Greater thanMa 20041.944
OpenGreater thanClose49.640
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-06-302021-09-302021-12-312022-03-312022-06-30
Accumulated Other Comprehensive Income  -46,08713,126-32,9618,679-24,2825,674-18,60828,85910,251



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets1,804,057
Total Liabilities1,986,275
Total Stockholder Equity-182,218
 As reported
Total Liabilities 1,986,275
Total Stockholder Equity+ -182,218
Total Assets = 1,804,057

Assets

Total Assets1,804,057
Total Current Assets694,676
Long-term Assets694,676
Total Current Assets
Cash And Cash Equivalents 158,158
Short-term Investments 347,387
Net Receivables 135,943
Inventory 15,004
Other Current Assets 38,184
Total Current Assets  (as reported)694,676
Total Current Assets  (calculated)694,676
+/-0
Long-term Assets
Property Plant Equipment 206,548
Goodwill 82,341
Intangible Assets 760,154
Other Assets 60,338
Long-term Assets  (as reported)1,109,381
Long-term Assets  (calculated)1,109,381
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities567,371
Long-term Liabilities1,418,904
Total Stockholder Equity-182,218
Total Current Liabilities
Short-term Debt 160,980
Short Long Term Debt 149,908
Accounts payable 22,881
Other Current Liabilities 383,510
Total Current Liabilities  (as reported)567,371
Total Current Liabilities  (calculated)717,279
+/- 149,908
Long-term Liabilities
Long term Debt Total 282,460
Capital Lease Obligations Min Short Term Debt6,120
Long-term Liabilities Other 999,334
Deferred Long Term Liability 137,110
Long-term Liabilities  (as reported)1,418,904
Long-term Liabilities  (calculated)1,425,024
+/- 6,120
Total Stockholder Equity
Common Stock71
Retained Earnings -2,376,770
Accumulated Other Comprehensive Income 10,251
Capital Surplus 2,184,230
Total Stockholder Equity (as reported)-182,218
Total Stockholder Equity (calculated)-182,218
+/-0
Other
Capital Stock71
Cash and Short Term Investments 505,545
Common Stock Shares Outstanding 71,373
Common Stock Total Equity71
Liabilities and Stockholders Equity 1,804,057
Net Debt 441,310
Net Invested Capital 250,150
Net Tangible Assets -1,024,713
Net Working Capital 127,305
Short Long Term Debt Total 599,468



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312005-12-312004-12-31
> Total Assets 
38,968
43,974
44,148
0
0
0
13,072
64,406
175,468
167,244
151,903
255,840
237,558
220,795
333,219
299,520
273,822
396,100
368,041
335,232
305,563
288,177
269,345
248,645
383,078
367,720
391,653
379,411
511,773
1,028,627
1,119,222
1,283,911
1,291,572
1,641,486
1,623,782
1,545,592
1,476,637
2,181,059
2,208,278
2,111,941
2,058,669
2,007,325
1,938,056
1,799,591
1,804,057
1,804,0571,799,5911,938,0562,007,3252,058,6692,111,9412,208,2782,181,0591,476,6371,545,5921,623,7821,641,4861,291,5721,283,9111,119,2221,028,627511,773379,411391,653367,720383,078248,645269,345288,177305,563335,232368,041396,100273,822299,520333,219220,795237,558255,840151,903167,244175,46864,40613,07200044,14843,97438,968
   > Total Current Assets 
0
0
0
0
0
0
4,595
56,572
168,158
160,138
145,024
249,380
230,314
213,516
323,571
289,761
264,574
384,164
355,949
326,434
297,434
280,607
261,286
240,727
226,972
221,259
249,063
241,996
375,646
313,281
320,857
479,079
474,966
806,862
779,284
691,922
605,024
1,244,174
1,231,745
1,122,365
1,066,233
1,011,140
954,368
774,009
694,676
694,676774,009954,3681,011,1401,066,2331,122,3651,231,7451,244,174605,024691,922779,284806,862474,966479,079320,857313,281375,646241,996249,063221,259226,972240,727261,286280,607297,434326,434355,949384,164264,574289,761323,571213,516230,314249,380145,024160,138168,15856,5724,595000000
       Cash And Cash Equivalents 
6,777
10,964
28,432
0
0
0
2,726
54,747
154,095
24,045
15,414
115,855
21,172
52,873
49,748
36,825
29,220
140,712
58,022
40,165
35,658
50,286
58,321
54,106
133,011
141,838
111,792
97,675
223,788
206,913
169,498
201,144
136,094
523,577
288,028
123,287
158,461
433,970
208,812
146,632
177,347
189,818
189,718
144,178
158,158
158,158144,178189,718189,818177,347146,632208,812433,970158,461123,287288,028523,577136,094201,144169,498206,913223,78897,675111,792141,838133,01154,10658,32150,28635,65840,16558,022140,71229,22036,82549,74852,87321,172115,85515,41424,045154,09554,7472,72600028,43210,9646,777
       Short-term Investments 
26,210
26,876
0
0
0
0
0
0
11,583
133,183
127,053
130,730
205,687
156,516
265,493
243,642
225,999
230,809
280,903
258,547
237,235
198,052
173,345
148,471
48,058
27,472
79,454
80,595
72,318
42,491
58,088
206,018
227,447
185,072
398,535
472,572
340,430
707,049
894,838
841,774
769,734
678,125
583,658
443,615
347,387
347,387443,615583,658678,125769,734841,774894,838707,049340,430472,572398,535185,072227,447206,01858,08842,49172,31880,59579,45427,47248,058148,471173,345198,052237,235258,547280,903230,809225,999243,642265,493156,516205,687130,730127,053133,18311,58300000026,87626,210
       Net Receivables 
0
0
0
0
0
0
1,014
946
871
784
958
838
858
1,296
4,445
3,178
5,114
8,016
11,094
22,618
19,765
27,409
24,929
32,173
33,767
38,744
40,394
45,611
59,383
42,197
67,907
46,350
77,104
60,383
55,538
52,623
53,644
56,786
69,929
94,124
78,801
96,645
110,455
141,288
135,943
135,943141,288110,45596,64578,80194,12469,92956,78653,64452,62355,53860,38377,10446,35067,90742,19759,38345,61140,39438,74433,76732,17324,92927,40919,76522,61811,0948,0165,1143,1784,4451,2968588389587848719461,014000000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,300
1,700
1,354
6,912
7,792
10,754
12,355
13,852
13,660
16,117
16,219
16,897
17,107
19,285
19,133
18,373
19,481
18,697
16,234
16,441
15,613
15,856
15,281
15,004
15,00415,28115,85615,61316,44116,23418,69719,48118,37319,13319,28517,10716,89716,21916,11713,66013,85212,35510,7547,7926,9121,3541,7001,300000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
8,477
7,833
7,310
7,106
6,878
6,460
7,244
7,279
9,648
9,759
9,248
11,936
12,092
8,798
8,129
7,570
8,059
7,918
156,106
146,461
142,590
137,415
136,127
715,346
798,365
804,832
816,606
834,624
844,498
853,670
871,613
936,885
976,533
989,576
992,436
996,185
983,688
1,025,582
1,109,381
1,109,3811,025,582983,688996,185992,436989,576976,533936,885871,613853,670844,498834,624816,606804,832798,365715,346136,127137,415142,590146,461156,1067,9188,0597,5708,1298,79812,09211,9369,2489,7599,6487,2797,2446,4606,8787,1067,3107,8338,477000000
       Property Plant Equipment 
5,205
4,702
10,795
0
0
0
8,280
7,676
7,154
6,942
6,729
6,328
6,417
6,193
9,159
9,408
9,017
8,799
8,974
8,426
7,601
7,059
7,429
7,059
6,839
6,882
8,376
8,302
8,217
8,805
12,694
14,540
15,391
18,484
21,549
26,169
26,806
113,951
118,241
119,505
123,604
125,053
130,006
135,181
206,548
206,548135,181130,006125,053123,604119,505118,241113,95126,80626,16921,54918,48415,39114,54012,6948,8058,2178,3028,3766,8826,8397,0597,4297,0597,6018,4268,9748,7999,0179,4089,1596,1936,4176,3286,7296,9427,1547,6768,28000010,7954,7025,205
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
148,138
138,422
132,993
127,565
126,290
100,309
82,341
82,341
82,341
82,341
82,341
82,341
82,341
82,341
82,341
82,341
82,341
82,341
82,341
82,341
82,341
82,34182,34182,34182,34182,34182,34182,34182,34182,34182,34182,34182,34182,34182,34182,341100,309126,290127,565132,993138,422148,138000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
148,138
138,422
132,993
127,565
126,290
604,612
701,031
694,955
702,729
702,910
710,500
705,294
708,814
712,536
715,328
712,574
717,079
723,260
724,841
763,665
760,154
760,154763,665724,841723,260717,079712,574715,328712,536708,814705,294710,500702,910702,729694,955701,031604,612126,290127,565132,993138,422148,138000000000000000000000000
       Long-term Assets Other 
0
0
0
0
0
0
197
158
156
163
149
132
827
1,086
489
351
231
3,137
3,118
372
528
511
630
859
1,129
1,157
1,221
1,548
1,620
1,620
2,299
12,996
16,145
30,889
30,108
39,866
53,652
28,057
60,623
75,156
69,412
65,531
46,500
44,395
60,338
60,33844,39546,50065,53169,41275,15660,62328,05753,65239,86630,10830,88916,14512,9962,2991,6201,6201,5481,2211,1571,1298596305115283723,1183,1372313514891,086827132149163156158197000000
> Total Liabilities 
4,355
5,573
68,373
0
0
0
32,267
30,328
22,548
16,212
15,360
11,498
13,802
19,499
34,752
26,200
25,241
126,949
142,040
139,231
139,939
148,000
149,762
147,818
213,347
221,838
235,216
229,103
244,371
642,537
768,495
770,969
802,887
977,832
1,029,452
1,016,858
904,143
1,670,105
1,726,296
1,819,365
1,862,092
1,902,399
1,936,618
1,890,172
1,986,275
1,986,2751,890,1721,936,6181,902,3991,862,0921,819,3651,726,2961,670,105904,1431,016,8581,029,452977,832802,887770,969768,495642,537244,371229,103235,216221,838213,347147,818149,762148,000139,939139,231142,040126,94925,24126,20034,75219,49913,80211,49815,36016,21222,54830,32832,26700068,3735,5734,355
   > Total Current Liabilities 
4,128
4,646
43,145
0
0
0
28,159
27,327
19,788
13,921
13,133
9,239
11,583
17,262
32,475
23,905
23,082
31,695
45,386
43,889
42,909
48,926
49,624
45,418
67,985
71,899
82,048
72,716
86,474
114,922
166,796
143,046
173,959
183,500
235,857
217,668
201,843
253,822
277,333
250,949
290,962
465,261
509,348
476,776
567,371
567,371476,776509,348465,261290,962250,949277,333253,822201,843217,668235,857183,500173,959143,046166,796114,92286,47472,71682,04871,89967,98545,41849,62448,92642,90943,88945,38631,69523,08223,90532,47517,26211,5839,23913,13313,92119,78827,32728,15900043,1454,6464,128
       Short-term Debt 
0
0
0
0
0
0
0
0
2,747
84
49
12
0
0
0
0
0
0
91,848
0
0
0
98,216
99,895
141,242
143,091
144,971
146,878
1,666
6,667
11,667
16,667
20,000
20,000
20,000
20,000
18,333
5,859
8,741
9,027
9,456
159,059
159,813
158,862
160,980
160,980158,862159,813159,0599,4569,0278,7415,85918,33320,00020,00020,00020,00016,66711,6676,6671,666146,878144,971143,091141,24299,89598,21600091,8480000001249842,74700000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
91,848
0
0
0
98,216
99,895
141,242
143,091
144,971
146,878
1,666
6,667
11,667
16,667
20,000
20,000
20,000
20,000
18,333
0
0
0
0
149,358
149,540
149,721
149,908
149,908149,721149,540149,358000018,33320,00020,00020,00020,00016,66711,6676,6671,666146,878144,971143,091141,24299,89598,21600091,848000000000000000000
       Accounts payable 
1,703
1,183
1,878
0
0
0
622
269
10,058
10,205
12,207
8,735
11,341
16,493
29,121
23,532
23,082
31,695
45,247
43,493
42,183
47,759
48,759
45,153
63,996
64,054
76,446
71,437
82,534
102,788
128,199
98,450
122,375
128,150
159,276
145,386
164,376
218,561
18,665
19,114
20,820
21,462
23,033
18,365
22,881
22,88118,36523,03321,46220,82019,11418,665218,561164,376145,386159,276128,150122,37598,450128,199102,78882,53471,43776,44664,05463,99645,15348,75947,75942,18343,49345,24731,69523,08223,53229,12116,49311,3418,73512,20710,20510,0582696220001,8781,1831,703
       Other Current Liabilities 
1,501
2,985
34,127
0
0
0
23,093
23,235
6,984
3,631
877
492
242
769
3,354
373
19,676
22,980
139
396
726
1,167
865
265
3,989
7,845
5,602
1,279
2,274
5,467
26,930
27,929
31,584
35,350
56,581
52,282
19,134
232,167
245,776
220,921
260,686
284,740
326,502
299,549
383,510
383,510299,549326,502284,740260,686220,921245,776232,16719,13452,28256,58135,35031,58427,92926,9305,4672,2741,2795,6027,8453,9892658651,16772639613922,98019,6763733,3547692424928773,6316,98423,23523,09300034,1272,9851,501
   > Long-term Liabilities 
0
0
0
0
0
0
4,108
3,001
2,760
2,290
2,227
2,259
2,219
2,237
2,277
2,295
2,159
95,254
96,654
95,342
97,030
99,074
100,138
102,400
145,362
149,939
153,168
156,387
157,897
527,615
601,699
627,923
628,928
794,332
793,595
799,190
702,300
1,416,283
1,448,963
1,568,416
1,571,130
1,437,138
1,427,270
1,413,396
1,418,904
1,418,9041,413,3961,427,2701,437,1381,571,1301,568,4161,448,9631,416,283702,300799,190793,595794,332628,928627,923601,699527,615157,897156,387153,168149,939145,362102,400100,13899,07497,03095,34296,65495,2542,1592,2952,2772,2372,2192,2592,2272,2902,7603,0014,108000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
93,198
94,608
93,366
94,936
96,559
98,216
99,895
141,242
143,091
144,971
146,878
147,204
144,258
141,347
138,468
135,683
293,149
293,859
294,574
297,029
302,971
309,145
430,038
430,496
281,604
281,894
282,176
282,460
282,460282,176281,894281,604430,496430,038309,145302,971297,029294,574293,859293,149135,683138,468141,347144,258147,204146,878144,971143,091141,24299,89598,21696,55994,93693,36694,60893,19800000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
-2,747
-84
-49
-12
0
0
0
0
0
0
-91,848
0
0
0
-98,216
-99,895
-141,242
-143,091
-144,971
-146,878
-1,666
-6,667
-11,667
-16,667
-20,000
-20,000
-20,000
-20,000
7,878
105,533
102,552
97,916
96,478
-54,482
-55,868
-58,614
6,120
6,120-58,614-55,868-54,48296,47897,916102,552105,5337,878-20,000-20,000-20,000-20,000-16,667-11,667-6,667-1,666-146,878-144,971-143,091-141,242-99,895-98,216000-91,848000000-12-49-84-2,74700000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
2,518
2,290
2,227
2,259
2,219
2,237
2,277
2,295
2,159
2,056
2,046
1,976
2,094
2,515
335
311
292
269
243
209
10,693
268,157
338,320
367,423
371,213
379,151
368,874
373,754
274,409
982,449
1,003,083
663,227
666,221
671,925
1,008,266
994,110
999,334
999,334994,1101,008,266671,925666,221663,2271,003,083982,449274,409373,754368,874379,151371,213367,423338,320268,15710,6932092432692923113352,5152,0941,9762,0462,0562,1592,2952,2772,2372,2192,2592,2272,2902,51800000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
242
0
0
0
0
0
0
0
0
0
0
0
0
0
1,587
2,194
3,828
6,579
7,954
9,300
0
115,200
122,032
122,032
122,032
122,032
130,862
130,862
130,862
130,863
136,735
136,735
136,735
136,733
137,110
137,110
137,110
137,110137,110137,110136,733136,735136,735136,735130,863130,862130,862130,862122,032122,032122,032122,032115,20009,3007,9546,5793,8282,1941,587000000000000024200000000
> Total Stockholder Equity
34,613
38,401
0
0
0
0
0
29,578
152,920
151,032
136,542
244,342
223,756
201,296
298,467
273,320
248,581
269,151
226,001
196,001
165,624
140,177
119,583
100,827
169,731
145,882
156,437
150,308
267,402
386,090
350,727
512,942
488,685
663,654
594,330
528,734
572,494
510,954
481,982
292,576
196,577
104,926
1,438
-90,581
-182,218
-182,218-90,5811,438104,926196,577292,576481,982510,954572,494528,734594,330663,654488,685512,942350,727386,090267,402150,308156,437145,882169,731100,827119,583140,177165,624196,001226,001269,151248,581273,320298,467201,296223,756244,342136,542151,032152,92029,5780000038,40134,613
   Common Stock
0
0
0
0
0
0
1
1
24
24
24
30
30
30
33
33
34
34
34
34
34
34
34
34
41
41
42
42
47
51
51
58
58
61
62
62
67
68
70
70
70
70
71
71
71
7171717070707068676262615858515147424241413434343434343434333330303024242411000000
   Retained Earnings Total Equity-2,376,770-2,224,683-2,097,957-1,954,717-1,821,093-1,702,723-1,628,877-1,554,523-1,484,831-1,303,404-1,190,499-1,112,822-1,052,825-1,011,036-938,923-890,600-839,624-830,100-814,100-815,378-781,640-764,165-735,108-708,313-673,145-634,231-592,998-542,050-498,827-460,466-422,551-395,282-368,000-342,896-328,798-310,912-306,49600000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
-20,286
0
0
0
-22,683
-22,683
0
0
-1,000
-1,000
0
-1,000
-1,000
1,000
1,000
1,000
-1,000
-1,000
2,000
3,000
4,000
5,000
2,000
2,000
1,000
1,000
2,000
1,000
-11,000
-2,000
-10,000
-36,000
-60,957
-38,743
-46,087
-32,961
-24,282
-18,608
10,251
10,251-18,608-24,282-32,961-46,087-38,743-60,957-36,000-10,000-2,000-11,0001,0002,0001,0001,0002,0002,0005,0004,0003,0002,000-1,000-1,0001,0001,0001,000-1,000-1,0000-1,000-1,00000-22,683-22,683000-20,286000000
   Capital Surplus 
0
0
0
0
0
0
0
0
459,392
461,961
465,246
587,128
591,636
596,617
721,722
734,489
747,869
812,294
820,165
829,114
837,850
847,700
856,142
865,834
949,331
958,206
966,534
975,418
1,105,124
1,275,004
1,288,137
1,523,115
1,539,530
1,775,799
1,795,351
1,834,061
2,067,274
2,101,136
2,171,746
2,033,972
2,063,687
2,092,534
2,123,606
2,152,639
2,184,230
2,184,2302,152,6392,123,6062,092,5342,063,6872,033,9722,171,7462,101,1362,067,2741,834,0611,795,3511,775,7991,539,5301,523,1151,288,1371,275,0041,105,124975,418966,534958,206949,331865,834856,142847,700837,850829,114820,165812,294747,869734,489721,722596,617591,636587,128465,246461,961459,39200000000
   Treasury Stock000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
-1
-40
70
80
90
-69
-737
-736
-495
-1,127
-1,200
1,084
885
756
-1,485
-876
1,999
3,013
3,969
4,953
1,855
1,628
1,462
805
1,922
616
-10,584
-1,985
-10,016
2,101,409
2,171,746
2,033,972
2,063,687
2,092,534
2,123,606
-18,608
2,184,230
2,184,230-18,6082,123,6062,092,5342,063,6872,033,9722,171,7462,101,409-10,016-1,985-10,5846161,9228051,4621,6281,8554,9533,9693,0131,999-876-1,4857568851,084-1,200-1,127-495-736-737-69908070-40-100000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue538,593
Cost of Revenue-32,328
Gross Profit506,265506,265
 
Operating Income (+$)
Gross Profit506,265
Operating Expense-881,208
Operating Income-374,443-374,943
 
Operating Expense (+$)
Research Development540,684
Selling General Administrative285,273
Selling And Marketing Expenses-
Operating Expense881,208825,957
 
Net Interest Income (+$)
Interest Income-
Interest Expense-86,022
Net Interest Income-86,022-86,022
 
Pretax Income (+$)
Operating Income-374,443
Net Interest Income-86,022
Other Non-Operating Income Expenses-57,875
Income Before Tax (EBT)-518,340-230,546
EBIT - interestExpense = -518,340
-518,340
-437,879
Interest Expense86,022
Earnings Before Interest and Taxes (ebit)-432,318-432,318
Earnings Before Interest and Taxes (ebitda)-368,184
 
After tax Income (+$)
Income Before Tax-518,340
Tax Provision-5,561
Net Income From Continuing Ops-523,901-523,901
Net Income-523,901
Net Income Applicable To Common Shares-523,901
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses913,536
Total Other Income/Expenses Net-143,897143,897
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications